HMPL-295S1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HMPL-295S1, covering 2024-10-15 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of HMPL-295S1 in Patients With Advanced Malignant Solid Tumors [Phase 1]